Jack A. Khattar - Jul 30, 2021 Form 4/A - Amendment Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role: President, CEO, Director
Signature: /s/ Timothy C. Dec, as attorney-in-fact
Stock symbol: SUPN
Transactions as of: Jul 30, 2021
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 1/13/2023, 04:00 PM
Date Of Original Report: Jul 30, 2021
Previous filing: Jun 10, 2021
Next filing: Oct 7, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	SUPN	Common Stock						516K	Jul 30, 2021	Direct
holding	SUPN	Common Stock						1.06M	Jul 30, 2021	By the KBT Trust
holding	SUPN	Common Stock						4K	Jul 30, 2021	By Son	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SUPN	Performance Share Unit	Award	$0	+40K		$0.00	40K	Jul 30, 2021	Common Stock	40K	$0.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person disclaims beneficial ownership of the shares held by his son, who shares the Reporting Person's household, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose.
F2	On February 19, 2021, the Reporting Person was awarded Performance Shares Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period.